A375 Transfection Reagent (Melanoma Cells, CRL-1619)

The A375 cancer cell line (CRL-1619) was established using the skin cells from female patient that was diagnosed with melanoma, A375 cell line is used as a transfection host for melanoma research.  Tranfection reagents designed for A375 cells are commonly used for melanoma research studies by cancer research centers worldwide. Transfection reagents for melanoma cell lines have been developed and manufactured by companies such as  Altogen Biosystems . These transfection reagents can be used in research studies involving the co-transfection of RNA and DNA molecules, such as plasmid DNA and small interfering RNA (siRNA).  Transfection Reagent for A375 Cell s

A-431 (CRL-1555) cancer cell line was established by DJ Giard and SA Aaronson from the solid tumor of a female patient suffering from epidermoid carcinoma; in cancer research, A431 cell line is used in medical research to study oncology treatments of skin cancer and is commonly used as a transfection host cell line.  A431 transfection reagent is manufactured by  Altogen Biosystems  and  has been reported to have a 81% transfection efficacy for the delivery of small RNA molecules. This reagent is functionally tested in vitro and has been proven to facilitate the development of A431 stable cell lines. In addition, A-431 transfection reagents for epidermoid carcinoma cell line work in the presence of serum and it is used in both reverse and standard transfection protocols.  Transfection Reagent for A431 Cells